GlaxoSmithKline Plc’s suit against Ranbaxy Laboratories in the U.S. District Court for the District of New Jersey for alleged infringement of its Valtrex(R) patent was settled in late 2009, according…
GlaxoSmithKline Plc remains in dispute with Neolab (UK) over the infringement of its Seretide combination patent in Germany.
In October 2007, GlaxoSmithKline filed a complaint with the Patent Dispute Chamber of…
SmithKline Beecham’s patent infringement case against Barr Laboratories is in the discovery phase, according to GlaxoSmithKline Plc’s Form 20-F filed with the U.S. Securities and Exchange Commission on March 4,…
Roche Laboratories’ Boniva patent infringement actions against several generic drug manufacturers are ongoing, according to GlaxoSmithKline Plc’s Form 20-F filed with the U.S. Securities and Exchange Commission on March 4,…
GlaxoSmithKline Plc and the U.S. Patent and Trademark Office await a decision by the U.S. Court of Appeals for the Federal Circuit (CAFC) regarding rules governing patent applications and claims.
In…